 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in the large medical device market also pose a tough...

Boston Scientific (BSX) Faces Rising Costs, Competition

Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE Nav Pulsed Field Ablation Catheter and FARAVIEW Software Module Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE Nav Pulsed...

Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE Nav Pulsed Field Ablation Catheter and FARAVIEW Software Module

Boston Scientific (NYSE:BSX - Free Report) had its target price boosted by Citigroup from $71.00 to $79.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Citigroup...

Boston Scientific (NYSE:BSX) Price Target Raised to $79.00

Boston Scientific Co. (NYSE:BSX - Get Free Report) EVP John Bradley Sorenson sold 16,351 shares of the firm's stock in a transaction dated Monday, April 1st. The stock was sold at an average price of...

Boston Scientific Co. (NYSE:BSX) EVP Sells $1,133,124.30 in Stock

Breakwater Capital Group increased its stake in Boston Scientific Co. (NYSE:BSX - Free Report) by 8.3% during the fourth quarter, according to the company in its most recent disclosure with the...

Breakwater Capital Group Has $424,000 Stock Position in Boston Scientific Co. (NYSE:BSX)

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info...

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Boston Scientific price target raised by $8 at Citi, here's why

Latest Ratings for BSX
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform
 View More Analyst...

Unveiling 13 Analyst Insights On Boston Scientific

Insider Sell: EVP, Global Operations John Sorenson Sells 16,351 Shares of Boston Scientific ...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Volume (M)	729,039.00
52-Wk High	$69.21
52-Wk Low	$48.35

BSX Boston Scientific Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals